SCHEMBL3418691

SCHEMBL3418691

CCOc1ccc(-c2cccc(C(=O)O)c2)cc1CNC(=O)c1ccc(Cl)cc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 8/20 0.56
PPARA Q07869 5/20 0.56
PPARG P37231 4/20 0.52
ACLY P53396 1/20 0.49
HDAC1 Q13547 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
NPC1 O15118 2/20 0.47
NFKB1 P19838 1/20 0.47
RAB9A P51151 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TP53 P04637 1/20 0.46
PTPN11 Q06124 1/20 0.44
MRGPRX4 Q96LA9 1/20 0.44
EPHX2 P34913 1/20 0.44
POLB P06746 1/20 0.44
THRB P10828 1/20 0.44
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3417151 0.93 PPARD (0.61) PPARDPPARAPPARGACLYTP53
SCHEMBL3413584 0.91 PPARD (0.66) PPARDPPARAPPARGACLYMRGPRX4
SCHEMBL3414230 0.90 PPARA (0.63) PPARDPPARAPPARGACLYHDAC1
SCHEMBL3419182 0.90 PPARD (0.56) PPARDPPARAPPARGACLYNPC1
SCHEMBL3414385 0.88 PPARD (0.55) PPARDPPARAPPARGACLYNPC1
SCHEMBL3413583 0.88 PPARD (0.59) PPARDPPARAPPARGPTPN11
SCHEMBL3416703 0.88 PPARD (0.63) PPARDPPARAPPARGACLYNPC1
SCHEMBL3417095 0.88 PPARD (0.51) PPARDPPARAPPARGACLYMRGPRX4
SCHEMBL3415410 0.86 SCN2A (0.50) PPARDPPARAPPARGACLYNPC1
SCHEMBL13461052 0.86 PPARG (0.47) PPARDPPARAPPARGACLYHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687664-B2 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-30 US disclosed
US-7687664-B2 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-30 US disclosed
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-10-28 US disclosed
EP-1394147-A1 CARBOXYLIC ACID DERIVATIVE AND MEDICINE COMPRISING SALT OR ESTER OF THE SAME Eisai Co., Ltd. (JP) 2004-03-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same GPR119, NR3C1, INSR PPARD 689/4885PPARA 130/4885PPARG 238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.